12/10/2024
7:00 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:54 PM | Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
8:34 AM | Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/04/2024
1:09 PM | Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/13/2024
3:31 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:16 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:38 PM | Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
3:40 PM | Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:10 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for STRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
07/10/2024
3:11 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:29 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
3:31 PM | Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:21 PM | Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:22 PM | Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:24 PM | Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
4:59 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:10 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:58 PM | Sutro Biopharma (Filer)
| Form 424B5 | |
04/02/2024
5:04 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:28 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4/A | |
03/07/2024
6:12 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:28 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:31 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:32 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:40 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:29 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:15 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:33 PM | Sutro Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2024
11:16 AM | Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
02/09/2024
3:27 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:56 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again? Click here for his emergency broadcast... |
